Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002822
Accepted
2024-09-13 00:15:10
Documents
1
Effectiveness Date
2024-09-12
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-24-002822.txt   1715
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-281903 | Film No.: 241296361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)